Cargando…

Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets

BACKGROUND: Pituitary adenomas are common brain tumors. Although transsphenoidal surgery are able to achieve extensive tumor removal, the rate of recurrence ranges from 5 to 20% depending on the different subtype. Further understanding of these tumors is needed to develop novel strategies to improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Jie, Gao, Hua, Zhang, Qi, Zhou, Yang, Li, Chuzhong, Zhao, Sida, Hong, Lichuan, Yang, Jinjin, Hao, Shuyu, Hong, Wan, Zhuang, Zhengping, Xu, Guowang, Zhang, Yazhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712670/ https://www.ncbi.nlm.nih.gov/pubmed/31455412 http://dx.doi.org/10.1186/s12967-019-2042-9

Ejemplares similares

Integration of Proteomics and Metabolomics Revealed Metabolite–Protein Networks in ACTH-Secreting Pituitary Adenoma
por: Feng, Jie, et al.
Publicado: (2018)

Analysis of the Prognostic and Immunological Role of HSPB1 in Pituitary Adenoma: A Potential Target for Therapy
por: Zhao, Sida, et al.
Publicado: (2023)

The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2019)

Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2020)

CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition
por: Li, Bin, et al.
Publicado: (2019)

The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas
por: Zhenye, Li, et al.
Publicado: (2014)

Risk factors and management associated with postoperative cerebrospinal fluid leak after endoscopic endonasal surgery for pituitary adenoma
por: Li, Bin, et al.
Publicado: (2022)

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
por: Liu, Chunhui, et al.
Publicado: (2016)

Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
por: Guo, Jing, et al.
Publicado: (2021)

Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
por: Nie, Ding, et al.
Publicado: (2021)

Alterations of regional homogeneity and functional connectivity in pituitary adenoma patients with visual impairment
por: Song, Guidong, et al.
Publicado: (2017)

Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype
por: Chen, Yiyuan, et al.
Publicado: (2020)

Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data
por: Zhao, Peng, et al.
Publicado: (2015)

Identification of Transcriptional Metabolic Dysregulation in Subtypes of Pituitary Adenoma by Integrated Bioinformatics Analysis
por: Hu, Jintao, et al.
Publicado: (2019)

Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness
por: Yu, Guoqiang, et al.
Publicado: (2017)

Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence
por: Guo, Jing, et al.
Publicado: (2021)

Corrigendum to “Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data”
por: Zhao, Peng, et al.
Publicado: (2018)

Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas
por: Yao, Xiaohui, et al.
Publicado: (2017)

A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
por: Cheng, Sen, et al.
Publicado: (2021)

Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model
por: Cheng, Sen, et al.
Publicado: (2019)

Comparative Efficacy of AZD9496 and Fulvestrant on the Growth of Pituitary Adenoma via Blocking JAK2/STAT5B Pathway
por: Liu, Qian, et al.
Publicado: (2023)

Quantitative Ubiquitinomics Revealed Abnormal Ubiquitinated ATP7A Involved in Down-Regulation of ACTH in Silent Corticotroph Adenomas
por: Zhao, Sida, et al.
Publicado: (2022)

A two-circRNA signature predicts tumour recurrence in clinical non-functioning pituitary adenoma
por: Guo, Jing, et al.
Publicado: (2019)

Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas
por: Xie, Weiyan, et al.
Publicado: (2016)

Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles
por: Cheng, Sen, et al.
Publicado: (2019)

Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma
por: Cheng, Sen, et al.
Publicado: (2020)

In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma
por: Yuan, Taoyang, et al.
Publicado: (2021)

LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis
por: Zhao, Peng, et al.
Publicado: (2021)

Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas
por: Yao, Xiaohui, et al.
Publicado: (2019)

Effects of Anterior Pituitary Adenomas’ Hormones on Glucose Metabolism and Its Clinical Implications
por: Li, Mengnan, et al.
Publicado: (2023)

JAG1, Regulated by microRNA-424-3p, Involved in Tumorigenesis and Epithelial–Mesenchymal Transition of High Proliferative Potential-Pituitary Adenomas
por: Chen, Yiyuan, et al.
Publicado: (2020)

The Apoptosis Regulator 14-3-3η and Its Potential as a Therapeutic Target in Pituitary Oncocytoma
por: Zhao, Sida, et al.
Publicado: (2019)

CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
por: Xie, Weiyan, et al.
Publicado: (2014)

Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
por: Zheng, Xin, et al.
Publicado: (2015)

DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling
por: Feng, Jie, et al.
Publicado: (2019)

Whole-exome sequencing identifies variants in invasive pituitary adenomas
por: Lan, Xiaolei, et al.
Publicado: (2016)

The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
por: Kim, Jee Soon, et al.
Publicado: (2016)

Drp1-Mediated Mitochondrial Metabolic Dysfunction Inhibits the Tumor Growth of Pituitary Adenomas
por: Fan, Kexia, et al.
Publicado: (2022)

Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas
por: Lin, Kunzhe, et al.
Publicado: (2022)

The lipid metabolism gene FTO influences breast cancer cell energy metabolism via the PI3K/AKT signaling pathway
por: Liu, Yazhuo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rdpra01eck5k3thre7k9qv2g6i